Fundz

Teleflex finalizes acquisition of Biotronik's business

PUBLIC · TFXJul 02, 2025

Acquiring Company

Teleflex

Acquired Company

BIOTRONIK Neuro

WayneBerlinBiotechnologyHealth CareMedicalMedical DeviceManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Teleflex has completed the acquisition of Biotronik's vascular intervention business for $895 million. This acquisition enables Teleflex to enhance its clinical trial program and expand its innovative product offerings in the cath lab. The deal aims to improve patient care and strengthen Teleflex's global presence. The completion was announced earlier than expected by Teleflex's CEO, Liam Kelly.

Quick answer

Teleflex is acquiring BIOTRONIK Neuro, announced July 2, 2025. Teleflex is based in Wayne, Pennsylvania, United States.

How much did Teleflex pay for BIOTRONIK Neuro?
The deal value was not disclosed.
What does Teleflex do?
Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives.
Where are Teleflex and BIOTRONIK Neuro based?
Teleflex is based in Wayne, Pennsylvania, United States. BIOTRONIK Neuro is based in Berlin, Berlin, Germany.
Who are the decision-makers at Teleflex?
Fundz holds 2 contacts at Teleflex. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Medical Device

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Teleflex, and when

When Teleflex changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Teleflex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Teleflex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Teleflex. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Teleflex

Location

550 E Swedesford Rd

Wayne, Pennsylvania, United States

About

Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. The company specializes in vascular intervention, surgical instruments, and anesthesia technologies. Teleflex is committed to investing in innovative solutions to enhance patient care and outcomes. They operate in numerous markets worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Teleflex makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Tim
Likely contact at this company
••••••••@••••••••

See Tim's verified email →

Ainsley
Likely contact at this company
••••••••@••••••••

See Ainsley's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Teleflex's next move

Learn about Strategic plan

Frequently asked

Who acquired BIOTRONIK Neuro?

BIOTRONIK Neuro was acquired by Teleflex, based in Wayne. The deal was reported on July 2, 2025. Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. The company specializes in vascular intervention, surgical instruments, and anesthesia technologies. Teleflex is publicly traded (TFX) and operates in Biotechnology.

When did Teleflex acquire BIOTRONIK Neuro?

Teleflex's acquisition of BIOTRONIK Neuro was reported on July 2, 2025. Teleflex has completed the acquisition of Biotronik's vascular intervention business for $895 million. This acquisition enables Teleflex to enhance its clinical trial program and expand its innovative product offerings in the cath lab. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does BIOTRONIK Neuro do?

BIOTRONIK Neuro is a division of BIOTRONIK, a leading global medical device company. The division specializes in innovative technologies for neuromodulation and spinal cord stimulation. It is privately held, operating in Manufacturing, and is based in Berlin.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.